Outlook Therapeutics, Inc. reported on March 13, 2026, that it entered into a Note Purchase Agreement on March 16, 2026, to issue an unsecured promissory note for $18,360,000 with Atlas Sciences, LLC, to partially repay a prior convertible promissory note for $17,000,000.